New Commercial Leadership: Kirk Stockwood Joins Octave – Read More
New Commercial Leadership: Kirk Stockwood Joins Octave – Read More
OCTAVE EVENTS
April 18 - 22, 2026
Chicago, Illinois
Real-world Utilization of a Novel Multi-analyte Blood-based Biomarker Panel, the Octave® Multiple Sclerosis Disease Activity (MSDA) Test in Clinical Practice Across the United States
Presenter: Darin T. Okuda, MD, FAAN, UT Southwestern
Date: Sunday 04/19/26, 5:18 – 5:30 PM CDT
Session: 8 – Multiple Sclerosis: Imaging, Biomarkers, and Environmental Exposures
Honing Discovery of Plasma Protein Biomarkers for Profiling Early Parkinson’s Disease Progression
Presenter: David Brazel, PhD, Octave
Date: Wednesday 04/22/26, 2:00 – 2:12 PM CDT
Session: 43 – Movement Disorders: Biomarkers, Mechanisms, and Pathophysiology
Real-world Utility and Usability of the Multiple Sclerosis Disease Activity (MSDA) Blood Test: The Provider Experience
Date: Monday 04/20/26, 11:45 AM – 12:45 PM CDT
Session: P5 Poster Session, Poster 18-006
Pre- and Post-diagnosis Blood Biomarker Trajectories from Cross-sectional Data in the U.K. Biobank
Date: Monday 04/20/26, 5:00 PM – 6:00 PM CDT
Session: P6 Poster Session, Poster 16-015
Reanalysis of Global Neurodegeneration Proteomics Consortium Data Uncovers Pervasive Risk of False Positives and False Negatives in Biomarker Discovery from Large, Multi-center Proteomic Studies
Date: Monday 04/20/26, 5:00 PM – 6:00 PM CDT
Session: P6 Poster Session, Poster 16-014
Vice President, Medical Affairs
Principal Medical Science Liaison
Associate Medical Director, Field
Vice President,
Data Science
Senior Director of Medical Affairs, Parkinson's
Staff Data Scientist
